Specialty / Expertise

Breast Cancer

Research Interests

Current Research Projects

Research Staff

Training

Dr. Linden received her MD from the University of Massachusetts, Amherst, MA. She completed her Internal Medicine Residency at the University of Arizona, Tuscon, AZ. She was a Post-Doctoral Fellow in Hematology at the University of Washington, Seattle, WA.

Selected Publications:

Krohn KA, O'Sullivan F, Crowley J, Eary JF, Linden HM, Link JM, Mankoff DA, Muzi M, Rajendran JG, Spence AM, Swanson KR. Challenges in clinical studies with multiple imaging probes. Nucl Med Biol 2007 34(7):879-885.

Sundararajan L, Linden HM, Link JM, Krohn KA, Mankoff DA. 18F-Fluoroestradiol. Semin Nucl Med 2007 37(6):470-476.

Linden HM, Reisch LM, Hart A Jr, Harrington MA, Nakano C, Jackson JC, Elmore JG. Attitudes toward participation in breast cancer randomized clinical trials in the African American community: a focus group study. Cancer Nurs 2007 30(4):261-269.

Linden HM, Haskell CM, Green SJ, Osborne CK, Sledge GW Jr, Shapiro CL, Ingle JN, Lew D, Hutchins LF, Livingston RB, Martino S. Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313). J Clin Oncol 2007 25(6):656-661.

Specht JM, Tam SL, Kurland BF, Gralow JR, Livingston RB, Linden HM, Ellis GK, Schubert EK, Dunwald LK, Mankoff DA. Serial 2-[18F] flouro-2-deoxy-d-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP). Breast Cancer Res Treat 2007 105(1):87-94.

Linden HM, Haskell CM, Green SJ, Osborne CK, Sledge, Jr. GW, Shapiro CL, Ingle JN, Lew D, Hutchins LF, Livingston RB, Martino S. Sequenced vs. simultaneous anthracycline and cyclophosphamide in high risk stage I-II breast cancer: final analysis from INT-0137 (S9313). J Clin Oncol 2007 Feb 20;25(6):656-661.

Linden HM, Reisch LM, Nakano C, Harrington M, Jackson C, Hart A, Elmore JG. Attitudes toward participation in breast cancer screening and randomized clinical trials in the African American community: a focus group study. Cancer Nursing 2007 30(2):1-10.